Diametric Capital’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Diametric Capital's PHAT Position: Q3 2026 in Review
Diametric Capital opened a new position in Phathom Pharmaceuticals (PHAT) in Q3 2026: 76,957 shares worth $562K. The stake represents 0.05% of the portfolio and ranks #338 among its holdings.
161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Diametric Capital held 76,957 shares of Phathom Pharmaceuticals worth $562K as of Q3 2026.
- Phathom Pharmaceuticals was a new Diametric Capital position in Q3 2026.
- Phathom Pharmaceuticals made up 0.05% of Diametric Capital's portfolio in Q3 2026, its #338 holding.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.